ClinicalTrials.gg
RecruitingNCT07949721RREMSUpdated Nov 19, 2026

Impact of Remote Exercise on Sleep in PD

An interventional study of High intensity resistance exercise in PARKINSON DISEASE (Disorder), sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Treatment

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 34 studies in Parkinson Disease by University of Colorado, Denver — 8 open to participants now, 11 under way, none of them phase 3. Parkinson Disease · University of Colorado, Denver.

Planned enrollment
17th of 24
20 · median 46
Started
2026
with 2 others
No phase
18 of 34
6 open now
Primary completion
2028-08
later than 10 of 10 live
Registered
34th of 34
by date

Among the 34 studies in Parkinson Disease by University of Colorado, Denver, this one is the 17th largest by planned enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2026, is one of 18 with no phase, reaches primary completion later than 10 of the 10 other live ones, and was the 34th registered.

Parkinson Disease

4,581 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

8 of the 34 studies in Parkinson Disease by University of Colorado, Denver are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 313 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Parkinson Disease by University of Colorado, Denver, or all of them as a file.
02

Study summary

The purpose of this study is to see the impact of 12 weeks of remote resistance exercise on remotely measured sleep quality for people with Parkinson's Disease.

Read the detailed description

This proof-of-concept study aims to evaluate the feasibility and acceptability of a 12-week remote high-intensity resistance exercise (rHIRE) intervention in people with PD and to assess its impact on real-world sleep quality. Participants will participate in three exercise sessions per week for 12 weeks. All exercise sessions will be completed over Zoom using the secure CU Anschutz Zoom account. After participants complete the strength assessments, they will be sent a link to the exercises, with descriptions and videos, which will be provided immediately before the first session via MedBridge, an online platform for home exercise programs. A neurologic physical therapist (PI) will virtually supervise the first week of exercise sessions. Exercises will be adjusted to make them easier or more difficult to find the exercise intensity at which the participant can complete 10 repetitions without form failure or an RPE above 7/10. During the second week of exercise sessions, the second session will be an assessment, where participants will complete the session under supervision but with no cueing or information from the supervisor. If the participant and the PI feel comfortable with the participant doing the session without supervision, they will transition to doing two sessions a week without supervision. The third session will be supervised and will focus on progression of intensity, checking form, and answering questions. If they do not feel ready, they will continue to be fully supervised until the next week, when the assessment will be completed again. Participants will fill out the Resistance Exercise Tracking Log each session, with or without supervision. They will be instructed to write the intensity of the exercises and their heart rate as recorded by the Fitbit.

03

Conditions studied

  • PARKINSON DISEASE (Disorder)

Keywords

  • Exercise
  • Sleep
  • PD
  • Parkinson's Disease
  • Virtual
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Parkinson's Disease
  • Has strong internet access at home
  • Has experience with the Zoom platform
  • Has a study partner at home that can be present throughout the study

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled medical conditions
  • Exercising more than 5 days a week for at or more than moderate level intensity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Exercise Intervention

    Behavioral: High intensity resistance exercise

Interventions

  • BehavioralHigh intensity resistance exercise

    Remote high intensity resistance training

06

What researchers measure

Primary outcomes

  1. Objective Sleep

    Objective sleep will be measured using the Waveband sleep headband by measuring sleep efficiency (amount of time in bed is actually spent asleep), with a higher number being a better outcome

    Time frame: Baseline and the week after completing the exercise intervention

  2. Subjective Sleep

    Subjective sleep will be measured using the Pittsburgh Sleep Quality Index (score from 0 to 21, the lower the score, the better the outcome)

    Time frame: Baseline and the week after completing the exercise intervention

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Aug 2028, 21 months after the start.

Of 1,295 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 21 months is below that.

Counting every sponsor, half of 1,371 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 19, 2026
StartActual
Oct 30, 2026
Primary completionEst.
Aug 1, 2028
CompletionEst.
Aug 1, 2028
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07949721
Responsible party
Sponsor
First posted
Nov 19, 2026
Start date
Oct 30, 2026
Primary completion
Aug 1, 2028 (estimated)
Completion
Aug 1, 2028 (estimated)
Last update
Nov 19, 2026

Study contacts

Lina Kleinschmidt, PhD Student
Contact
NeuroResearch@CUAnschutz.edu
303-724-4644

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion